and linezolid 600 mg twice daily. At that time the patient was also receiving venlafaxine 150 mg nocte for depression.
Twenty days after commencing the oral antibiotic regimen the patient was noted to be confused and disorientated, with disturbance of his sleep-wake cycle, and was intermittently aggressive. A computed tomography scan of the brain did not reveal any significant abnormality, serum biochemistry was normal, full blood examination (FBE) showed normal white cell count and there was no clinical evidence of sepsis. His vital signs were within the normal range and clinical examination did not reveal a specific reason for his altered mental status. Four days later the patient became drowsy and was transferred from the rehabilitation centre to an acute hospital. There he was found to have a reduced level of consciousness and fever of 37.68C. He had widespread increased tone, generalized myoclonic jerks and down-going plantar reflexes. FBE and electrolytes did not show any significant abnormality and creatinine kinase was within the normal range. A drug reaction was suspected; linezolid and venlafaxine were stopped. Within 2 days the patient had recovered to his usual level of mental functioning. The most likely diagnosis was serotonin syndrome due to the interaction between linezolid and venlafaxine.
Serotonin syndrome is caused by excessive central nervous system and peripheral serotonergic activity, predominantly 5HT-1a (5-hydroxytryptamine).
1 This is usually due to drug interactions between agents that promote release of serotonin, or inhibit the reuptake or metabolism of serotonin in the intersynaptic space. Onset may be acute or delayed after instigation of offending agents. The syndrome manifests as altered mental status, including agitation, confusion and coma, neuromuscular hyperactivity (restlessness, myoclonus, hyperreflexia, tremors), and autonomic dysfunction. 1 It may be clinically confused with neuroleptic malignant syndrome (NMS), although resolution is generally faster, creatinine kinase levels are only minimally raised in proportion to the degree of rigidity and the 'lead-pipe' rigidity seen in NMS is absent.
The diagnosis is based on clinical signs and symptoms and an appropriate drug history. 1 Treatment is symptomatic, although the use of serotoninreceptor antagonists may speed resolution. Cyproheptadine is a drug with 5HT-1a and 5HT-2 receptor blocking activity, and may be used. 1 Linezolid is the first member of the synthetic oxazolidinone family of antimicrobials to be used in clinical practice. This group of drugs was originally developed as monoamine-oxidase inhibitors for the treatment of depression, but was subsequently noted to have antimicrobial properties against Gram-positive organisms and was further developed for this purpose. 2 As an antimicrobial, linezolid inhibits bacterial ribosomal protein synthesis, preventing formation of the 70S initiation complex. This unique process precludes cross-resistance to other agents. 2 Linezolid is active against major Gram-positive pathogens, Neisseria spp., Nocardia spp. and possibly Mycobacteria spp. It has 100% bioavailability, does not require dosage adjustment for renal or hepatic disease and comes in oral and intravenous forms. Other than reversible marrow suppression, the drug has a very favourable side-effect profile and is tolerable to patients. 2 These factors all make linezolid a very attractive option for the treatment of complicated Gram-positive infections on an outpatient basis.
A Phase III study of linezolid included 52 patients receiving concomitant linezolid and an SSRI with no reports of serotonin syndrome. Given the limited treatment experience with these agents in combination, physicians were alerted to be aware of the potential for interaction. 3 Serotonin syndrome has been reported in a patient receiving low-dose venlafaxine (a serotonin noradrenergic reuptake inhibitor) alone; however, it is most commonly caused by drug interactions. 4 The syndrome has been now been described as being the result of interaction between linezolid and citalopram, and linezolid and paroxetine. 5, 6 Linezolid is a useful antimicrobial that has a role in treating difficult Gram-positive infections. There is an increasing body of reports of clinically important interactions between linezolid and serotonergic antidepressant drugs. Physicians need to be continually aware of the potential for significant interactions, particularly in these groups of patients with complex infections, in whom depression is common. Sir, Post-neurosurgical meningitis is a serious complication. When this disease is caused by a multidrug-resistant pathogen, the management of such a case is challenging. Multidrug-resistant Acinetobacter baumanii has become one of the more common nosocomial pathogens in hospitals. Infections caused by this bacterium are more common in patients with severe underlying diseases, and after multiple courses of antibiotic treatment. 1 When the infection involves the meninges, the choice of an antibiotic is further limited by the blood-brain barrier. Intrathecal treatment is often the last resort in such cases. 2 Polymyxins have not been used frequently, and in cases of multiple resistance, might be one of the only options. This class of antibiotic has been given intrathecally only to very few patients. 3, 4 We present a case of Acinetobacter meningitis, cured by intrathecal polymyxin E.
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A 49-year-old woman had a history of recurrent craniotomies (in another hospital) due to a recurrent meningioma in the base of her skull. She was blind in both eyes and anosmic, since the first operation in 1989. Her history included serious complications such as CSF leak and recurrent meningitis. She first presented to our neurosurgical department in 1999 with recurrence of the tumour in the lower frontal lobes and invasion of the sphenoidal, ethmoidal and right maxillary sinuses. In the first operation in our department, which was carried out via subcranial approach, the tumour was totally removed with reconstruction of the large bone defect at the base of the skull using an artificial dural patch. On the fourth day after surgery, her temperature was 388C and she was lethargic. Piperacillin -tazobactam was started as empirical treatment. On the 11th day, her temperature was 40.28C with CSF rhinorrhoea, evidenced by high glucose levels in the fluid. Meropenem and vancomycin were substituted for the piperacillin-tazobactam combination. On the 18th day, she developed signs of septic shock. After haemodynamic resuscitation, she was operated on again, the artificial dural patch was removed and the base of the skull reconstructed with fascia lata. Microscopy of the patch tissue revealed Gram-negative bacilli. Ceftazidime and ciprofloxacin were given, while continuing vancomycin. After 3 days, cultures obtained during surgery grew Acinetobacter baumannii and Enterobacter cloacae. Blood and CSF cultures were negative. Six days later, she was fully alert with daily peaks of fever up to 388C. All the antibiotics were stopped after the completion of the course. Four days later, she developed meningitis and CSF rhinorrhoea. Ceftriaxone, co-amoxiclav and meropenem were started. Acinetobacter was cultured from the CSF leak. Minocycline was added after culture results were available. Because of CSF leak, she was operated on again; this time trans-nasal endoscopic insertion of a fascia lata patch was carried out. During the following 3 weeks, she was febrile with fluctuations in her consciousness. High pressure of CSF during lumbar puncture and enlarged ventricles on CT scan, diagnosed communicating hydrocephalus. A ventriculo-peritoneal shunt was inserted, after negative CSF cultures were available. No other source of the fever could be found on physical examination and imaging studies. As a result of massive CSF leak, the base of the skull was reconstructed again, this time with a free galeal flap from her fronto-temporo-parietal scalp. Cultures from the removed flap grew Acinetobacter, methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacter. Ampicillin-sulbactam and vancomycin were started. There was no clinical response.
As a result of multiple adhesions in the peritoneal cavity, the peritoneal end of her shunt was externalized. CSF cultures, obtained from the external shunt after removal of 'dead space' CSF, grew Acinetobacter baumannii, resistant to all cephalosporins, aminoglycosides and carbapenems, except for sulbactam and polymyxin E. The isolates from the patch and CSF obtained from the shunt shared the same antibiogram. Culture results during her hospital course are summarized in Table 1 .
Treatment with intrathecal polymyxin E (colistin), 40 000 units per day was administered through the external shunt. Six days later, her temperature was normal. In the next days she was fully alert and cooperative. After 17 days of intrathecal treatment with polymyxin E, all antibiotics were discontinued. After a further 10 days, the distal part of her ventricular shunt was reinserted into the peritoneal cavity. After four more days, the patient was discharged. Four years follow-up revealed no signs of meningitis or CSF leak.
Post-operative meningitis in neurosurgery is a serious complication. The causative organisms are not the usual pathogens causing meningitis, but rather the opportunistic organisms implicated in hospital-acquired infections. These vary according to local flora. The Acinetobacter isolated was susceptible only to sulbactam and polymyxins. This multi-resistant isolate was possibly due to prolonged treatment with multiple antibiotics. Sulbactam is bacteriostatic for this bacterium. 5 Experience with this drug is limited to one case report. 6 We elected to treat the patient with intrathecal polymyxin E, 4 in spite of the numerous central nervous system side effects that have been reported, and the limited experience with this treatment modality. Rapid improvement of the patient's mental status and the disappearance of fever and other inflammatory symptoms proved that this rare application of polymyxin is effective in Gram-negative meningitis.
